Furthering its move into the neonatal space, this morning non-invasive patient monitoring device and sensor maker Masimo announced that it landed FDA clearance for its acoustic respiration sensor, the ...

Masimo Corporation MASI recently announced the receipt of the FDA’s clearance for Stork for prescription use with healthy and sick infants aged 0-18 months of age. Stork, Masimo’s innovative baby ...

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI), a global leader in innovative monitoring technologies used in top hospitals, announced today FDA clearance of Stork™, a revolutionary baby ...

NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today the CE marking of the rainbow ® Super DCI ®-mini sensor, a reusable spot-check sensor that features Masimo SET ® ...

Though Owlet, like Masimo, informed users that its products weren’t medical devices, the FDA took issue with the fact that a connected app would issue alerts if the Smart Sock’s readings left ...

Masimo has received a go-ahead from its board of directors to carve out its consumer-focused businesses, slimming itself down to focus on professional patient monitoring devices and telehealth ...